Clinical trial
Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
NCT05986968 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
- Lead sponsor
- Radboud University Medical Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 6, 2023
- Completion date
- December 12, 2026
- Enrollment
- 200 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.